On September 8, 2023, Edward Jordan informed Humanigen, Inc. of his resignation from his position as Chief Commercial Officer of the Company, effective September 14, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | +19,900.00% |
|
0.00% | -83.33% |
May. 01 | Combined Hearing for Disclosure Statement and Plan Approved for Humanigen, Inc. | CI |
Apr. 12 | Combined Liquidation Plan and Disclosure Statement Filed by Humanigen, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-83.33% | 23.82K | |
+2.52% | 92.1B | |
-2.63% | 37.92B | |
-12.81% | 32.97B | |
+75.60% | 27.92B | |
-11.29% | 16.14B | |
-2.09% | 14.1B | |
-11.93% | 11.66B | |
+177.66% | 10.29B | |
-50.94% | 9.99B |
- Stock Market
- Equities
- HGENQ Stock
- News Humanigen, Inc.
- Humanigen, Inc. Announces Resignation of Edward Jordan as Chief Commercial Officer